Drinking liquids in thyroid cancer therapy with I-131
Phase 2
- Conditions
- Thyroid cancer.Malignant neoplasm of thyroid gland
- Registration Number
- IRCT2014051417684N1
- Lead Sponsor
- Shiraz university of medical science, Vice chancellor for research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
thyroid cancer patients who treated with I-131 at nuclear medicine department in Namazi Hospital, shiraz, Iran.
Exclusion criteria: vomitting
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Ambient equivalent dose. Timepoint: Before and after intervention. Method of measurement: Environmental dosimeter.
- Secondary Outcome Measures
Name Time Method Physiological characteristics of the patient. Timepoint: Before intervention. Method of measurement: Measurement and asking patient.